Drug Trial Radar · NCT00069641
Iduronate-2-sulfatase Enzyme Replacement Therapy in Mucopolysaccharidosis II (MPS II)
Last checked: Nov 20, 2026Latest source record: Jun 10, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
96
Actual
Start
Sep 18, 2003
Primary completion
Mar 16, 2005
Study completion Mar 16, 2005
Sponsor
- Lead sponsor
- ShireTakeda (TAK)
- Sponsor type
- Industry
- First posted
- Oct 1, 2003
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- Male only, from 5 years, up to 25 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether the administration of iduronate-2-sulfatase enzyme in a weekly or every other week therapy frequency is safe and efficacious in patients with MPS II.
Conditions
- Mucopolysaccharidosis II
Interventions
Iduronate-2-sulfatase enzyme replacement therapyBiological
Patients will receive weekly infusions of idursulfase at a dose of 0.5 mg/kg.
iduronate-2-sulfatase enzyme replacement therapyBiological
Patients will receive every other week infusions of idursulfase at a dose of 0.5 mg/kg.
PlaceboBiological
Patients will receive weekly infusions of placebo.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Ranked Adjusted 2-Component Composite Variable Score Based on Change From Baseline to Week 53Time frame: Baseline, Week 53
Locations
9 sites in 4 countries. Site status is shown where the registry gives one.
Children's Hospital Oakland
Oakland, California
St. Louis Children's Hospital, Washington University
St Louis, Missouri
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
Texas Children's Hospital, Baylor College of Medicine
Houston, Texas
Hospital de Clinicas de Porto Alegre
Porto Alegre, Brazil
Children's Hospital, Johannes-Gutenburg Universitaet Mainz
Mainz, Germany
Addenbrooke's Hospital
Cambridge, England, United Kingdom
Great Ormond Street Hospital for Sick Children
London, England, United Kingdom
Royal Manchester Children's Hospital
Manchester, England, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.